Detecting Drug Resistance in Pancreatic Cancer Organoids Guides Optimized Chemotherapy Treatment

0
75
Investigators determined if patient-derived organoids (PDOs) could be used to personalize poly-chemotherapy regimens by pharmacotyping of treatment-naïve and post neoadjuvant chemotherapy PDAC PDOs.
[Journal of Pathology]
AbstractFull Article